Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DGX - Quest Diagnostics, Inc.


Close
156.97
0.740   0.471%

Share volume: 883,728
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$156.23
0.74
0.47%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
2.22%
1 Month
9.85%
3 Months
13.27%
6 Months
26.31%
1 Year
19.16%
2 Year
29.65%
Key data
Stock price
$156.97
P/E Ratio 
20.90
DAY RANGE
$155.49 - $157.34
EPS 
$7.45
52 WEEK RANGE
$116.97 - $157.34
52 WEEK CHANGE
$0.23
MARKET CAP 
17.473 B
YIELD 
1.85%
SHARES OUTSTANDING 
111.317 M
DIVIDEND
$0.75
EX-DIVIDEND DATE
07/08/2024
NEXT EARNINGS DATE
10/22/2024
BETA 
0.22
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$574,604
AVERAGE 30 VOLUME 
$703,631
Company detail
CEO: Stephen Rusckowski
Region: US
Website: https://www.questdiagnostics.com/
Employees: 25,064
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator

Recent news